Clinical Trial Update: A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants [Phase 1]

View source ↗

Summary

Pfizer is studying PF-08049820 in a Phase 1 trial to see if it changes how the body processes oral contraceptives, midazolam, and dabigatran in healthy adult fe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Midazolam (Midazolam)
• Oral contraceptives (combined oral contraceptives)
• PF-08049820

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING